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Abstract
Purpose We previously showed that short-term intervention with barley kernel bread (BKB) improved glucose tolerance. 
However, glucose tolerance was not improved in a subset of individuals (non-responders) who were characterized by a low 
Prevotella/Bacteroides ratio. The purpose of the present study was to investigate if the baseline Prevotella/Bacteroides ratio 
can be used to stratify metabolic responders and non-responders to barley dietary fiber (DF).
Methods Fecal samples were collected from 99 healthy humans with BMI < 28 kg/m2 between 50 and 70 years old. The 
abundance of fecal Prevotella and Bacteroides was quantified with 16S rRNA quantitative PCR. 33 subjects were grouped in 
three groups: subjects with highest Prevotella/Bacteroides ratios, “HP”, n = 12; subjects with lowest Prevotella/Bacteroides 
ratios, “LP”, n = 13; and subjects with high abundance of both measured bacteria, HPB, n = 8. A 3-day randomized crossover 
intervention with BKB and white wheat bread (control) was performed. Cardiometabolic test variables were analyzed the 
next day following a standardized breakfast.
Results The BKB intervention lowered the blood glucose responses to the breakfast independently of Prevotella/Bacteroides 
ratios (P < 0.01). However, independently of intervention, the HP group displayed an overall lower insulin response and lower 
IL-6 concentrations compared with the LP group (P < 0.05). Furthermore, the groups HP and HPB showed lower hunger 
sensations compared to the LP group (P < 0.05).
Conclusions Here we show that the abundance of gut Prevotella and Bacteroides at baseline did not stratify metabolic 
responders and non-responders to barley DF intervention. However, our results indicate the importance of gut microbiota in 
host metabolic regulation, further suggesting that higher Prevotella/Bacteroides ratio may be favorable.
ClinicalTrials.gov ID NCT02427555
Keywords Prevotella · Bacteroides · Barley · Prevention · Stratification · Glucose regulation
Introduction
Lifestyle habits play a pivotal role for the development of 
obesity, type 2 diabetes (T2D) and cardiovascular disease 
(CVD) [1]. Diet is probably the most significant lifestyle Electronic supplementary material The online version of this article (https ://doi.org/10.1007/s0039 4-018-1788-9) contains 
supplementary material, which is available to authorized users.
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factor for the etiology of metabolic diseases, making the 
dietary composition an essential target in a strategy aim-
ing at prevention [1]. Recent studies have demonstrated that 
saturated fats and animal protein, which are typically high 
in a Western diet, are associated with metabolic disorders 
such as obesity, reduced insulin sensitivity, T2D, and CVD 
[2], and also altered microbiota, e.g., reduced diversity [3]. 
In contrast, inclusion of whole grain foods in the diet has 
been found advantageous by lowering the risk of weight 
gain, T2D, and CVD [4]. Accumulating evidence from both 
epidemiological studies [5] and dietary interventions [6–9] 
suggest preventive potential of dietary fiber (DF) on car-
diometabolic risk. The beneficial effects of DF are largely 
suggested to emanate from mechanisms related to microbial 
metabolism of the DF [6–10]. We and others have shown 
that barley kernel-based evening meals improve glucose 
tolerance following a subsequent standardized breakfast [6, 
7, 10]. The underlying mechanisms were suggested to ema-
nate from colonic fermentation of the DF present in barley. 
Recent studies have observed a high variability in the effects 
on glucose tolerance to food between subjects although the 
meals or more specific food items were identical [11, 12]. 
Thus, the importance of personalized nutrition is highlighted 
and it has been suggested that the glucose response can be 
predicted by collecting data regarding personal features and/
or gut microbiota composition [11, 12]. In agreement, we 
previously reported high variability in glucose response in 
test subjects following barley kernel-based evening meal 
[10]. Interestingly, we found that the microbiota differed 
between the subjects acquiring improved glucose tolerance 
after intake of barley (responder subjects) compared to 
subjects that showed no or minor effects on glucose toler-
ance (non-responder subjects). In responder subjects, intake 
of barley was associated with increased abundance of gut 
Prevotella and increased ratio of Prevotella/Bacteroides. In 
contrast, in non-responders, the abundance of Prevotella or 
ratio Prevotella/Bacteroides was not affected after barley 
kernel-based products. In addition, we observed tendencies 
towards an increased ratio of Prevotella/Bacteroides in the 
responder subjects compared with the non-responder sub-
jects already at baseline, i.e., prior to the barley intervention 
[10]. The purpose of this study was to investigate if the ratio 
Prevotella/Bacteroides at baseline can be used to identify 
and stratify metabolic responders from non-responders to 
barley DF in a population.
Materials and methods
Test subjects
Recruitments of subjects were conducted through adver-
tisements in local newspapers during May and June 2015. 
The screening was conducted at the Food for Health Sci-
ence Centre, Lund University. The inclusion criteria were 
as follows: men and women aged 50–70 years with normal 
to slightly increased body mass index (BMI < 28 kg/m2), 
normal blood glucose concentration as determined with a 
random blood glucose test < 8.7 mmol/l, overall healthy 
and with unknown metabolic disorders or food allergies. 
Subjects with anti-hypertensive medications (3 subjects) 
and prescription-free painkillers without anti-inflammatory 
action were allowed to participate. In addition, no antibiotics 
or probiotics should have been consumed within 3 weeks 
prior to fecal donation, during the selection process and 
throughout the following dietary intervention. In total, 99 
apparently healthy volunteers (as judged from the inclusion 
criteria), 25 men and 74 women, aged 64.1 (SD 5.6) years, 
with a BMI of 24.3 kg/m2 (SD 3.4 kg/m2) and with a random 
blood glucose concentration of 5.5 mmol/l (SD 0.8 mmol/l), 
donated stool samples at baseline, i.e., prior to start of the 
dietary intervention.
The study was conducted in accordance to the Declara-
tion of Helsinki, and all procedures involving human sub-
jects were approved by the Regional Ethical Review Board 
in Lund, Sweden (Reference 2015/58). Written informed 
consent was obtained from all the subjects. The study was 
registered at ClinicalTrials.gov (NCT02427555).
Genomic DNA purification and 16S rRNA 
quantitative PCR analysis
Fecal samples were collected at baseline from all 99 sub-
jects. The sample was immediately frozen (− 20 °C) and 
handed over to the experimental department within 24 h for 
continued storage at − 80 °C until analysis. Genomic DNA 
was purified from the feces of 99 subjects, using repeated 
bead beating [13]. 16S rRNA quantitative PCR was per-
formed with a CFX96 Real-Time System (Bio-Rad Labo-
ratories). Samples were analyzed in a 25-µl reaction mix 
consisting of 12.5 µl 1xSYBR Green Master Mix buffer 
(Thermo Scientific, Waltham, Massachusetts, USA), 0.2 µM 
of each primer and 5 µl of template DNA, water or genomic 
DNA. All reactions were performed in duplicate in one run. 
qPCR conditions were as reported previously: for Bacte-
roides and universal [14]; for Prevotella [15]; Standard 
curves of 16S rRNA PCR product of B. thetaiotaomicron, 
P. copri or Escherichia coli (for universal 16S rRNA qPCR) 
were created using serial tenfold dilution of the purified PCR 
product.
Selection of individuals for the short‑term dietary 
intervention
The selection of the individuals for the intervention study 
with barley kernel bread (BKB) and white wheat bread 
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(WWB) was based on their baseline microbiota composition. 
Main criteria for the subgrouping were the abundance (high 
‘H’ or low ‘L’) of Prevotella and Bacteroides and the ratio 
of Prevotella/Bacteroides in their baseline gut microbiota. 
Individuals with highest levels of Prevotella and low lev-
els of Bacteroides and ratio of Prevotella/Bacteroides more 
than 1.0 were identified as high Prevotella (HP) subjects. 
Individuals with low levels of Prevotella and high levels of 
Bacteroides and the ratio of Prevotella/Bacteroides equal 
to 0 were identified as low Prevotella (LP) subjects. Out of 
the total cohort of 99 subjects, we identified 15 HP subjects. 
Based on this number, we selected 15 LP subjects with the 
lowest Prevotella levels and the highest Bacteroides levels. 
Some of the individuals (n = 10) had high levels of Prevo-
tella and high levels of Bacteroides and were identified as 
high Prevotella and Bacteroides (HPB) subjects and also 
included in the intervention study.
An additional inclusion criterion for participation in the 
short-term intervention study was that the fasting level of 
plasma glucose should be below 6.1 mmol/l, i.e., below 
the level of impaired fasting glucose (6.1–6.9  mmol/l) 
according to the World Health Organization definition [16]. 
Six participants were excluded due to fasting plasma glu-
cose > 6.4 mmol/l (LP, n = 2; HP, n = 1 and HPB, n = 1) or 
a BMI > 30 kg/m2 (HP, n = 1 and HPB, n = 1). Due to the 
exclusions, the statistical evaluations were based on 12 sub-
jects in the HP group, 13 subjects in the LP group and 8 
subjects in the group HPB.
Test (BKB)—reference (WWB) products
The test product BKB consisted of a barley kernel-based 
bread containing 85% barley kernels (Finax) and 15% 
white wheat flour, presented as % cereal dry matter (dm). 
The reference product WWB consisted of a white wheat-
based bread and was based on 100% (dm) white wheat flour 
(Kungsörnen AB). The WWB was also included in the 
standardized breakfast. The BKB and WWB were charac-
terized with respect to total starch [17], resistant starch (RS) 
[18], and insoluble and soluble non-starch polysaccharides 
(NSP) [19]. Further details regarding characterization using 
these methods are provided elsewhere [6]. The starch and 
NSP compositions are presented in Table 1.
The ingredients and baking procedure of BKB and 
WWB are in accordance with previously used procedures 
[6], except that the barley kernels were boiled for 20 min 
instead of 12 min to obtain adequate cooked structure. After 
baking and cooling, the WWB was sliced into portion sizes 
and wrapped in aluminum foil, placed in plastic bags and 
stored in a freezer (– 20 °C). The BKB was placed in a 
plastic bag at room temperature overnight to obtain a firmer 
structure and facilitating the slicing into portions. The BKB 
then followed the procedure similar to the WWB. Before 
freezing, the crust was removed from the WWB included 
in the standardized breakfast. The subjects were instructed 
to take a daily portion of bread from the freezer on the day 
prior to consumption and to thaw it at ambient temperature, 
still wrapped in aluminum foil and maintained in the plastic 
bag. Study design and intervention protocol.
Study design and intervention protocol
The intervention study was conducted at the Food for Health 
Science Centre, Lund University, and was completed in May 
2016. The study design was crossover, with 3-day dietary 
intervention periods with BKB and WWB reference, respec-
tively, performed in a randomized order separated with a 
minimum of a 2-week wash-out period in-between inter-
vention periods. During the wash-out period, the subjects 
returned to their normal eating habits without diet restric-
tions or intake of test products. The daily quantity ingested 
of the test (BKB) and reference (WWB) products during 
Table 1  Characterization of 
test and reference product with 
respect to starch (total, available 
and resistant) and NSP
Data are presented as means
BKB barley kernel bread, RS resistant starch, NSP non-starch polysaccharides, DF dietary fiber, WWB 
white wheat bread
a Available starch was obtained by calculating the difference between total starch and RS. Values of total 
and available starch are based on means of 2 replications, RS means of 6 replications, DF means of 3 rep-
lications
Starch NSP Total DF
Products Daily amounts Total Availablea RS Insoluble Soluble
% dry matter
 BKB – 65.5 57.2 8.4 8.4 4.0 20.8
 WWB – 76.1 74.1 2.0 3.9 2.0 7.9
g/day
 BKB 384 115 100 14.7 14.7 7.0 36.4
 WWB 259 103 100 2.7 5.3 2.7 10.7
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the 3-day study periods was equivalent to 100 g potentially 
available starch per day (Table 1). The daily amount of prod-
uct was divided into three portions, and the subjects were 
instructed to distribute the daily intake of BKB or WWB 
over the day to suit their diet habits during day 1 and 2. On 
day 3, half of the daily intake (i.e., 50 g available starch) was 
distributed equally between meals consumed in the morning 
and in the afternoon, and the other half (i.e., 50 g available 
starch) was consumed in the evening at 2100 hours.
The subjects were encouraged to standardize their meal 
pattern and to avoid alcohol and foods rich in DF during the 
3-day intervention periods, and to avoid excessive physi-
cal activity on day 3. To facilitate the standardization of 
meal patterns and to monitor diet intake, the subjects were 
instructed to provide a meal record during the 3-day inter-
vention period. After intake of the last portion of the BKB 
or WWB evening meal on day 3, the subjects were fast-
ing until the next morning when the standardized breakfast 
was provided at the research unit. The subjects arrived at 
the research unit at 07.30 am, and an intravenous cannula 
(BD Venflon; Becton Dickinson) was inserted into an ante-
cubital vein for blood sampling. A fasting blood samples 
were obtained, and subjective appetite variables and breath 
hydrogen  (H2) determined, prior to the standardized break-
fast provided at approximately 08.00 h. The standardized 
breakfast corresponded to 50 g available carbohydrates and 
consisted of 129.6 g WWB, and was ingested together with 
2.5 dl tap water. The subjects were instructed to ingest the 
breakfast within 12 min. During the following experimental 
time period, the subjects were instructed to maintain low 
physical activity.
Collection and analysis of physiological variables
Venous blood samples were collected to analyze the serum 
(s-) insulin and s-free fatty acids (FFA) and the plasma 
(p-) glucagon-like peptide-1 (GLP-1), p-GLP-2, p-peptide 
YY (PYY), p-interleukin-6 (IL-6) and p-c-reactive pro-
tein (CRP). Capillary blood samples were taken via finger 
prick test to determine whole blood glucose concentrations, 
presenting the results in plasma (HemoCue®B-glucose; 
HemoCue AB). Indication of colonic fermentation activ-
ity was measured as breath hydrogen  (H2) excretion using 
a Gastro+ (Bedfont EC60 Gastrolyzer; Bedfont). Measure-
ments of subjective appetite sensations (satiety, hunger and 
desire to eat) were determined using a 100-mm visual analog 
scale.
Glucose,  H2 and appetite sensations were obtained at fast-
ing and at 15, 30, 45, 60, 90, 120, 150 and 180 min after 
the standardized breakfast. Insulin was analyzed at the same 
time points, excluding the 180 min time point. GLP-1 was 
analyzed at fasting and at 30, 60, 90, 120 and 180 min. GLP-
2, PYY and IL-6 were analyzed at fasting and at 60, 120 and 
180 min. FFA was determined at fasting and at 180 min, and 
CRP was analyzed at fasting. The plasma tubes were kept on 
ice (max 30 min) and serum tubes at room temperature (max 
1 h room temperature), after blood collection, then centri-
fuged and immediately frozen after separation and stored in 
a freezer until analysis (− 40 °C, except samples for GLP-1 
which were kept in − 80 °C). Assigned blood-collecting 
tubes for analysis of p-GLP-1, p-GLP-2 and p-PYY were 
prepared with a dipeptidyl peptidase-4 (DPPIV) inhibitor 
(10 µl/ml blood) (Millipore). Tubes prepared with DPPIV 
inhibitor were kept cold until use, for a maximum of 24 h.
Enzyme immunoassays were used for measuring lev-
els of s-insulin (Mercodia Insulin ELISA, Mercodia AB, 
Uppsala, Sweden), p-CRP (CRP ELISA Kit, Immundiag-
nostik AG, Bensheim, Germany), p-IL-6 (Quantikine® 
HS ELISA, Human IL-6 High Sensitivity HS600B, R&D 
Systems, Abingdon, UK), p-GLP-1 (GLP-1 (Active 7–36) 
ELISA 43-GP1HU-E01, ALPCO Diagnostics, Salem, NH), 
p-GLP-2 (Human GLP-2 EIA YK141, Yanaihara Institute 
Inc. Shizuoka, Japan) and p-PYY [both PYY (3–36) and 
PYY (1–36)] (Human PYY EIA YK080, Yanaihara Institute 
Inc. Shizuoka, Japan). Serum FFA levels were determined 
using an enzymatic colorimetric method (NEFA C, ACS-
ACOD method; Wako Chemicals GmbH).
Calculations and statistical methods
The statistical evaluations were performed with respect to 
investigations of effects of treatment (BKB and WWB) and 
baseline gut microbiota composition (subgroups: HP, LP 
and HPB), respectively, and interactions thereof, on the test 
variables included. The effects of treatment and baseline 
gut microbiota composition, respectively, as well as [Meal 
* Microbiota] interactions, on physiological markers were 
analyzed with repeated measures ANOVA (general linear 
model) applying a 2 × 3 factorial design including two even-
ing meals (BKB and WWB), i.e., ‘Meal’, and three base-
line gut microbiota compositions (HP, LP and HPB), i.e., 
‘Microbiota’, as independent main variables. The ANOVA 
was then followed by the post hoc analysis: Tukey’s pair-
wise multiple comparison method (MINITAB Statistical 
Software). In addition, a second approach of the factorial 
design was performed to further elucidate the differences 
in effects on the physiological markers depending on high- 
or low abundance of Prevotella and Bacteroides, excluding 
the HPB group. Thus, the ‘Microbiota’ variable in the 2 × 2 
factorial design included only the two “extreme” groups 
with respect to ratios of Prevotella/Bacteroides at baseline, 
i.e., the HP and LP subgroups. Furthermore, the metabolic 
responses depending on treatment were also evaluated sepa-
rately in each microbiota subgroup using one-way ANOVA 
analysis (MINITAB Statistical Software).
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Participants acted as their own control in the statistical 
evaluation. In the case of unevenly distributed residuals 
(tested using Anderson–Darling normality test and consid-
ered unevenly distributed if P < 0.05), transformation using 
Box Cox was performed on the data prior to the ANOVA 
analysis. Order of consumption of test and reference prod-
uct was randomized using the Random function in Micro-
soft Excel 2013 (Washington, USA). In case a value from 
a subject was missing for the test or reference product, the 
subject was excluded from that specific calculation. Data 
are expressed as means ± SEM and values of P < 0.05 are 
considered significant.
The statistical evaluations of glucose and insulin areas 
were based on both definite values and incremental changes 
from baseline to postprandial phase at the standardized 
breakfast consumed at day 4 (the day after the last portion 
of test product). Calculations of remaining test variables 
were performed using actual values. The trapezoid model 
was used to calculate the postprandial area and incremental 
area under the curve (AUC and iAUC, respectively) for each 
subject and test product. Graphs and calculations of areas 
were performed using Graph Prism (version 6; GraphPad 
Software). Postprandial mean values are reported instead 
of AUC and iAUC for test variables if the concentrations 
scarcely changed during the experimental day. Calcula-
tions of insulin resistance were made using a homoeostatic 
model assessment (HOMA-IR) formula [fasting glucose 
(mmol/l) × fasting insulin (mU/l)/22.5] [20]. Insulin sen-
sitivity was assessed using a modified composite insulin 
sensitivity  (ISIcomposite), also known as Matsuda index, and 
involved fasting and postprandial measures of b-glucose and 
s-insulin  (ISIcomposite: 10 000/square root of [fasting glucose 
(mg/dl) × fasting insulin (µU/ml) × mean glucose concentra-
tions 0–120 min (mg min/dl) × mean insulin concentrations 
0–120 min (µU min/ml)]) [21]. Modification of Matsuda 
index refers to that postprandial concentration of b-glucose 
and s-insulin was obtained after a WWB breakfast consist-
ing of 50 g rapidly available starch instead of 75 g glucose.
Results
Baseline abundance of gut bacteria and subject 
selection
To investigate if the baseline gut microbiota composi-
tion, in particular the abundance of Prevotella and the 
ratio Prevotella/Bacteroides, can identify individuals that 
will respond to short-term barley prebiotic intervention 
with improved glucose metabolism, we first quantified the 
abundance of Prevotella and Bacteroides in feces of 99 
subjects. From this cohort, we identified 15 subjects with 
highest abundance of Prevotella and lowest abundance of 
Bacteroides (group HP). Based on this, we selected 15 sub-
jects with the lowest abundance of Prevotella and highest 
abundance of Bacteroides that formed the LP group, and 
10 subjects with high abundance of both bacteria (group 
HPB) to be included in the short-term barley intervention. 
Of the selected subjects, 12 HP subjects, 13 LP subjects and 
8 HPB subjects (Table 2) completed the intervention and 
were included in the statistical evaluation (Fig. 1; Table 3); 
see the “Materials and methods” section for a comprehen-
sive description regarding selection of individuals and exclu-
sion criteria. The microbiota composition with respect to 
Prevotella and Bacteroides of the 59 subjects that were not 
included in the short-term intervention, are displayed in 
Fig. 1.
Effects of BKB vs WWB interventions on metabolic 
markers in subgroups varying in baseline gut 
microbiota composition
To investigate if abundance of Prevotella  and 
Prevotella/Bacteroides ratios can predict the metabolic 
response to BKB, we analyzed the metabolic responses in 
the subjects from the different microbiota subgroups (HP, 
HPB and LP).
Glucose and insulin
A main effect of treatment was observed on incremental 
postprandial b-glucose responses (iAUC 0–150 min) to the 
standardized breakfast (2 × 3 factorial design, P < 0.01), indi-
cating that the BKB intervention significantly lowered the 
b-glucose responses, compared to the WWB, in all three 
subgroups, i.e., independently of the baseline gut micro-
biota (Fig. 2). No main effects of intervention were detected 
on insulin responses to the standardized breakfast. Instead, 
baseline gut microbiota tended to impact the incremental 
postprandial s-insulin responses (iAUC 0–150 min) post the 
standardized breakfast (2 × 3 factorial design, P = 0.070), 
independently of intervention (Fig. 2).
The HPB group was excluded to facilitate the elucida-
tion of differences between the “extremes” with respect to 
Table 2  Age and BMI of the subjects in the three different microbiota 
subgroups as well as in the total group
Data including age and BMI are presented as means ± SD
P Prevotella, B Bacteroides, M men, W women
Microbiota group Gender (n subjects) Age (years) BMI (kg/m2)
HP (n = 12) 3 M/9 W 60.9 ± 7.1 24.1 ± 3.3
LP (n = 13) 2 M/11 W 65.8 ± 5.1 24.2 ± 2.7
HPB (n = 8) 4 M/4 W 65.8 ± 2.9 23.6 ± 3.9
Total (n = 33) 9 M/24 W 64.0 ± 5.8 24.0 ± 3.2
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the abundance of Prevotella (HP vs LP). When comparing 
s-insulin responses (iAUC 0–150 min) in these subgroups, 
we observed that the HP group had an overall lower insu-
lin response, compared to the LP group (2 × 2 factorial 
design, P < 0.05) (Fig. 2). No main effects of treatment or 
baseline microbiota were observed on fasting b-glucose 
and s-insulin concentrations (both ANOVA 2 × 3 and 2 × 2 
factorial designs, P > 0.05) (Table 4).
When investigating the treatment effects on b-glucose- 
and s-insulin concentrations in each subgroup separately 
(using one-way ANOVA), it was observed that 3-day BKB 
intervention, in comparison with the WWB intervention, 
increased the fasting b-glucose concentrations in the LP 
group (P < 0.05), whereas no such effects were seen in the 
other two subgroups (P > 0.05) (Table 4). The incremen-
tal postprandial s-insulin responses after the standardized 
breakfast (AUC 0–150 min and iAUC 0–150 min) were 
decreased after BKB intervention compared with WWB 
intervention in two subgroups: HP and LP, (P < 0.05, 
Table 4; Fig. 2). In addition, in the HP group, the BKB 
intervention showed a trend (− 6%, P = 0.067) towards 
lowering the postprandial b-glucose response (AUC 
0–150 min), see Table 4 and Fig. 2.
Gut hormones
No significant main effects of treatment or baseline micro-
biota composition were observed at fasting or with respect 
to mean concentrations of the gut hormones PYY, GLP-1 
or GLP-2 using the ANOVA 2 × 3 (all 3 subgroups) or 
2 × 2 (without HPB) factorial designs (Fig. 3 and data are 
displayed in Online resource 1). However, evaluation of 
treatment effects on gut hormone concentrations in each 
subgroup separately (using one-way ANOVA) displayed 
that the group HPB acquired significantly increased mean 
GLP-1 and GLP-2 concentrations (0–180 min) with 12 and 
6% respectively, after BKB intake compared to after WWB 
(P = 0.018 and P = 0.034) (Fig. 3 and Online resource 1). 
In the HP group, there was a trend towards increased fast-
ing concentration of p-PYY (11%, P = 0.050) and mean 
Fig. 1  Baseline levels of fecal bacteria and stratification of individu-
als. a Fecal levels of Prevotella and Bacteroides (determined by 
quantitative PCR and expressed as fraction of the total microbiota) in 
participants included and not included in the short-term barley prebi-
otic intervention. b Ratio of Prevotella vs Bacteroides in participants 
included and not included in the short-term barley prebiotic interven-
tion. Included HP (High Prevotella), LP (Low Prevotella) and HPB 
(High Prevotella and Bacteroides). ANOVA followed by post hoc 
analysis—Tukey’s pairwise multiple comparison method was used 
to compare changes in the levels of Prevotella and Bacteroides and 
the ratio Prevotella/Bacteroides across the four groups. Data are 
mean ± SEM. ***P < 0.001, ****P < 0.0001
Table 3  Abundance of 
Prevotella and Bacteroides, 
and Prevotella/Bacteroides 
ratio of the subjects in the three 
different microbiota subgroups
Data are presented as means ± SD
P/B ratio Prevotella/Bacteroides ratio
Microbiota group Prevotella, 16S copies Bacteroides, 16S copies P/B ratio
HP (n = 12) 1.32 × 108 ± 1.05 × 108 3.90 × 107 ± 3.29 × 107 6.67 ± 8.93
LP (n = 13) 1.12 × 105 ± 1.13 × 105 1.43 × 108 ± 8.77 × 107 0
HPB (n = 8) 5.27 × 107 ± 4.56 × 107 1.00 × 108 ± 7.76 × 107 0.63 ± 0.34
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concentrations of p-PYY (0–180 min, + 9%, P = 0.060) in 
the morning the day after the BKB intervention, compared 
to after WWB intervention (Fig. 3 and Online resource 1).
Breath hydrogen
Breath  H2 levels at both the fasting and mean (0–180 min) 
displayed a main effect of treatment (2 × 3 factorial design, 
P < 0.001) and of baseline gut microbiota composition 
(2 × 3 factorial design, P < 0.05) (data are presented in 
Online resource 1). The post hoc analysis (Tukey’s method) 
showed that the BKB intervention significantly increased 
the breath  H2 excretion in all subgroups, compared to WWB 
intervention (P < 0.001), and revealed that fasting  H2 levels 
were higher in the LP group compared with the HP group 
(P = 0.017) (Online resource 1).
Markers of inflammation
No significant main effects depending on treatment or base-
line gut microbiota composition were observed regarding 
the concentrations of p-IL-6 and p-CRP in the ANOVA 
2 × 3 factorial design (Fig. 4 and data are displayed in Online 
resource 2). However, comparing results in the HP and LP 
subgroups only (2 × 2 factorial design), a main effect of 
baseline gut microbiota composition was detected on con-
centrations of p-IL-6 (mean 0-180 min, P = 0.045), reveal-
ing lower IL-6 concentrations in the HP group (Fig. 4 and 
Online resource 2). In addition, the comparison of the CRP 
fasting concentrations in the subgroups HP and LP displayed 
a trend towards a main effect of baseline gut microbiota 
composition (2 × 2 factorial design, P = 0.084), indicating 
a trend towards lower CRP concentrations in the HP group 
(Fig. 4 and Online resource 2). No significant differences 
in concentrations of p-IL-6 or p-CRP were seen within the 
separate microbiota subgroups depending on treatment (one-
way ANOVA, P > 0.05) (Fig. 4 and Online resource 2).
Fig. 2  Incremental b-glucose 
(a) and s-insulin (b) responses 
post the standardized breakfast 
after BKB or WWB interven-
tions, respectively, in subgroups 
varying in baseline gut micro-
biota composition. One-way 
ANOVA was used to com-
pare the metabolic responses 
depending on intervention in 
each subgroup. The percentage 
corresponds to differences in 
concentration of test vari-
ables after BKB intervention 
compared to WWB interven-
tion. BKB barley kernel bread, 
WWB white wheat bread, HP 
high Prevotella, LP low Prevo-
tella and HPB high Prevotella 
and Bacteroides. Data are 
mean ± SEM. *P < 0.05
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Free fatty acids
No significant main effects depending on treatment or base-
line gut microbiota composition were observed regarding the 
concentrations of s-FFA in the ANOVA 2 × 3 or 2 × 2 facto-
rial design (data are displayed in Online resource 2). Neither 
were there any significant differences in concentrations of 
FFA within the separate microbiota subgroups depending on 
treatment (one-way ANOVA, P > 0.05).
Subjective appetite ratings
The postprandial appetite ratings ‘hunger’ and ‘desire to eat’ 
(AUC 0–180 min) displayed main effects of baseline gut 
microbiota composition (2 × 3 factorial, hunger, P < 0.05; 
desire to eat, P < 0.01) (Fig. 5 and data are presented in 
Online resource 3). The post hoc analysis (Tukey’s method) 
showed a significantly higher sensations of hunger and 
desire to eat in the LP group compared to both the HP group 
(hunger, P < 0.05; desire to eat, P < 0.01) and the HPB group 
(both variables, P < 0.05) (Fig. 5 and Online resource 3). 
No significant main effects were seen on subjective appetite 
ratings depending on treatment. However, investigations of 
effects of treatment in each subgroup separately, analyzed 
using one-way ANOVA, revealed significant effects of treat-
ment on appetite ratings in the LP group. Consequently, 
after the BKB intervention, the subgroup LP significantly 
decreased sensations of hunger at fasting (− 28%, P < 0.05) 
and increased fasting satiety (+ 92%, P < 0.01) (Online 
resource 3), and showed a trend to decrease postprandial 
desire to eat (AUC 0–180 min, − 15%, P = 0.082) (Fig. 5 
and Online resource 3), compared to the ratings after WWB 
intake.
Discussion
The purpose of this study was to investigate if the abundance 
of gut Prevotella and the ratio of Prevotella/Bacteroides at 
baseline may predict the effects of barley kernel-based food 
on cardiometabolic risk variables in a time perspective of, 
e.g., 11–13.5 h after intake. Therefore, subjects were strati-
fied into different subgroups (HP, LP and HPB) depending 
on the gut microbiota composition. We evaluated both the 
effects of the short-term 3-day interventions with BKB vs 
WWB and effects of microbiota subgroups on cardiometa-
bolic test variables. Effects of the interventions were also 
evaluated within each microbiota subgroup. The current 
design, 3-day long intervention with BKB, was based on 
previous findings where 3 days of intake of BKB was suf-
ficient to observe acute effects of gut microbiota and glucose 
metabolism [10].
All subgroups responded to the BKB intervention with 
improved glucose tolerance 11 h after intake as compared 
with the WWB intervention, thus, the results were not 
dependent on the subgroup stratification. Instead, we iden-
tified significant differences in cardiometabolic test mark-
ers between the microbiota subgroups independently of the 
intervention. Furthermore, the beneficial response to BKB 
can be driven by a substrate depending expansion of Prevo-
tella, regardless of the baseline levels gut Prevotella, which 
can mediate the improved glucose metabolism, in agreement 
to our previous findings [10].
Table 4  Fasting and postprandial measures of b-glucose, s-insulin 
and insulin sensitivity post the standardized breakfast after BKB or 
WWB, respectively, in subgroups varying in baseline gut microbiota 
composition
Data are presented as mean ± SEM
BKB barley kernel bread, WWB, white wheat bread
*Different from WWB P < 0.05, †P = 0.067 (One-way ANOVA)
a The percentage change is calculated as the difference from the WWB
WWB BKB
Mean SEM Mean SEM %Δa
Glucose
 b-Glucose, fasting (mmol/L)
  HP (n = 12) 5.6 0.1 5.6 0.1 1
  LP (n = 13) 5.3 0.2 5.5 0.2 6*
  HPB (n = 8) 5.5 0.2 5.7 0.2 5
 b-Glucose, AUC 0–150 min (mmol·min/L)
  HP (n = 12) 1090 38 1030 30 –  6†
  LP (n = 13) 1088 39 1062 39 – 2
  HPB (n = 8) 1127 67 1077 59 – 4
Insulin
 s-Insulin, fasting (nmol/L)
  HP (n = 12) 0.030 0.004 0.032 0.005 8
  LP (n = 13) 0.029 0.003 0.027 0.003 – 6
  HPB (n = 8) 0.029 0.005 0.033 0.006 13
 s-Insulin, AUC 0–150 min (nmol min/L)
  HP (n = 12) 21.6 2.7 18.3 2.2 – 15*
  LP (n = 13) 26.4 3.3 21.7 2.0 – 18*
  HPB (n = 8) 26.0 4.0 25.9 5.0 0
Insulin sensitivity
 HOMA-IR
  HP (n = 12) 1.23 0.17 1.34 0.22 8
  LP (n = 13) 1.12 0.14 1.14 0.13 2
  HPB (n = 8) 1.22 0.26 1.42 0.26 16
 ISIcomposite
  HP (n = 12) 9.44 1.14 11.05 1.96 17
  LP (n = 13) 8.96 0.98 9.59 1.06 7
  (n = 8) 10.2 2.43 8.97 1.68 – 12
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Colonic fermentation of DF endogenous to barley kernels 
has been related to improved cardiometabolic risk markers 
in healthy subjects [6, 7]. However, high variability between 
subjects in the metabolic responses to food, e.g., postpran-
dial glycemic responses, or SCFA production (in particu-
lar butyrate), has previously been observed, which may be 
related to gut microbiota composition [11, 12, 22]. In this 
context, we have previously shown that improved glucose 
tolerance after a short-term intervention with BKB was 
related to an enrichment of gut Prevotella, where P. copri 
was the most prevalent [10]. In addition, subjects respond-
ing to BKB with an improved glucose tolerance tended to 
have an elevated abundance of Prevotella also at baseline, 
prior to the BKB intervention. Prevotella can ferment a wide 
spectrum of complex carbohydrates, such as arabinoxylans 
and β-glucans, i.e., DF abundant in barley [23]. Populations 
Fig. 3  Mean concentrations of 
p-GLP-1 (a), p-GLP-2 (b) and 
p-PYY (c) after BKB or WWB 
intervention, respectively, in 
subgroups varying in gut micro-
biota composition. One-way 
ANOVA was used to com-
pare the metabolic responses 
depending on intervention in 
each subgroup. The percentage 
corresponds to differences in 
concentration of test variables 
after BKB intervention com-
pared to WWB intervention. 
GLP glucagon-like peptide, 
PYY peptide YY, BKB barley 
kernel bread, WWB white wheat 
bread, HP high Prevotella, 
LP low Prevotella and HPB 
high Prevotella and Bacte-
roides. Data are mean ± SEM. 
*P < 0.05, #P = 0.06
Fig. 4  Plasma concentrations of IL-6 (a) after the standardized break-
fast and fasting values of CRP (b) after BKB or WWB intervention, 
respectively, in subgroups varying in gut microbiota composition. 
One-way ANOVA was used to compare the metabolic responses 
depending on intervention in each subgroup. The percentage cor-
responds to differences in concentration of test variables after BKB 
intervention compared to WWB intervention. IL interleukin, CRP 
c-reactive protein, BKB barley kernel bread, WWB white wheat bread, 
HP high Prevotella, LP low Prevotella and HPB high Prevotella and 
Bacteroides. Data are mean ± SEM
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living in rural areas ingesting diets rich in DF have higher 
abundance of Prevotella compared to those on a Western 
diet [24]. Accordingly, Prevotella has been associated with 
high intake of carbohydrates/dietary fiber [25].
With respect to the metabolic effects of barley kernel-
based products, the results in the current study were in 
accordance with previous results showing beneficial effects 
on markers of glucose regulation, gut hormones, subjective 
appetite variables, and increased breath  H2 excretion [6, 7, 
26, 27]. Consequently, compared to WWB, the BKB inter-
vention resulted in improvements with respect to glucose 
tolerance in all subgroups, and insulin responses decreased 
in the subgroups HP and LP. Furthermore, gut hormones 
(GLP-1 and GLP-2) increased after BKB in the HPB 
group in the postprandial phase, whereas there was a trend 
(P = 0.05) towards increased PYY fasting concentrations in 
the HP group. In addition, the BKB intervention resulted in 
decreased sensation of hunger and increased satiety after 
BKB intervention in the LP group. Breath  H2 excretion was 
increased in all subgroups after the BKB intervention.
Interestingly, the main effects of baseline gut micro-
biota composition (HP, LP or HPB) were on appetite vari-
ables (hunger and desire to eat) and breath  H2, independent 
of the intervention. Thus, although the LP group improved 
appetite ratings after the BKB intervention, the post hoc 
analysis revealed that both subgroups with higher gut 
Prevotella abundance, i.e., the subgroups HP and HPB, in 
general displayed improved appetite sensations compared 
with the LP group with respect to less hunger and less 
desire to eat, independently of intervention. In addition, 
it was shown that the HP group had significantly lower 
breath  H2 concentrations at fasting, compared to the LP 
group. These findings further suggest differences in the 
gut microbiota fermentative activities between these two 
groups. Furthermore, the differences in insulin responses 
to the standardized breakfast between the microbiota sub-
groups that differ the most in composition, i.e., the HP 
and LP groups, revealed a significant effect of baseline 
gut microbiota composition, demonstrating that a high 
abundance of Prevotella and high Prevotella/Bacteroides 
ratio at baseline may be advantageous with respect to post-
prandial glucose homeostasis, compared to a low baseline 
Prevotella and low Prevotella/Bacteroides ratio.
Upon designing the study, we included 99 subjects with 
the intention to identify 20 subjects to be included in the 
HP group and 20 subjects in the LP group. However, fol-
lowing the initial microbial screening, we could not iden-
tify 20 subjects with high or low Prevotella, which limits 
the study design. Surprisingly, we identified subjects with 
relatively high levels of both Prevotella and Bacteroides 
(the HPB group), which is interesting as taxa belonging 
to these genera usually are believed to compete for the 
same niche [28].
Fig. 5  Subjective appetite 
ratings [subjective hunger (a), 
desire to eat (b) and satiety 
(c)] post standardized breakfast 
after BKB or WWB interven-
tion, respectively, in subgroups 
varying in gut microbiota 
composition. One-way ANOVA 
was used to compare the meta-
bolic responses depending on 
intervention in each subgroup. 
The percentage corresponds 
to differences in concentration 
of test variables after BKB 
intervention compared to WWB 
intervention. BKB barley kernel 
bread, WWB white wheat bread, 
HP high Prevotella, LP low 
Prevotella and HPB high Prevo-
tella and Bacteroides. Data are 
mean ± SEM. #P = 0.065
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In the present study, we focused on the potential changes 
in cardiometabolic test variables after BKB compared to 
WWB in healthy subjects after a short-term intervention 
depending on specific bacteria ratios. For future work, it 
would be interesting to design a longer term study and it 
could also be of interest to focus on prediabetic cohort and/
or different ages. Furthermore, the screening criteria for 
healthy subjects would also benefit from including HbA1c 
measurements to obtain further indication of the glycemic 
status.
In summary, the BKB intervention resulted in improved 
glucose tolerance after the forthcoming standardized break-
fast in all microbiota subgroups, suggesting overall prebiotic 
and anti-diabetic potentials of barley DF independently of 
Prevotella/Bacteroides ratio at baseline. There were no dif-
ferences between the microbiota subgroups in response to 
BKB, in comparison to WWB, with respect to the tested 
variables. Thus, our results do not support the hypothesis 
that the Prevotella/Bacteroides ratio at baseline can be used 
to stratify metabolic responders and non-responders to the 
prebiotic mixture present in BKB. However, these findings 
do not exclude that the beneficial effects of DF are medi-
ated by Prevotella-dependent fermentation. In addition, 
based on reduced insulin responses, reduced inflammatory 
markers and improved subjective appetite ratings in the HP 
group compared to the LP group (independent of interven-
tion), the results of the current study suggest that higher 
Prevotella/Bacteroides ratio may be advantageous with 
respect to cardiometabolic regulation, and may play a pre-
ventive role in the development of obesity, T2D and CVD.
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